Leucadia National Corporation »

Nektar Therapeutics shares owned by Leucadia National Corporation

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Leucadia National Corporation from 13F filings

Historical chart of Leucadia National Corporation investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Leucadia National Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Leucadia National Corporation

Quarter filed Position value Share count Share price at filing
2025-09-30 $17M 303k 56.90

More positions owned by Leucadia National Corporation

Spdr Gold Tr Gold Shs (GLD)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard World Inf Tech Etf (VGT)
Iren Ordinary Shares (IREN)
W.R. Berkley Corporation (WRB)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Costco Wholesale Corporation (COST)
Eli Lilly & Co. (LLY)
Ishares Tr Russell 2000 Etf (IWM)
Pepsi (PEP)
Select Sector Spdr Tr Energy (XLE)
Cadence Design Systems (CDNS)
Chevron Corporation (CVX)
Citigroup Com New (C)
Nxp Semiconductors N V (NXPI)

View all positions for Leucadia National Corporation

Top funds holding Nektar Therapeutics

Susquehanna International
BVF
Vanguard Group
Citadel Advisors
Farallon Capital Management
BlackRock
Millennium Management
Two Sigma Investments
Nantahala Capital Management
22NW
Emerald Advisers
Leucadia National Corporation
Dr. Jeffrey R. Jay, M.D.
PRIMECAP Management Company
Renaissance Technologies

View all funds holding Nektar Therapeutics